14M103: Abstracts: B Cell Biology and Targets in Autoimmune and Inflammatory Disease (1629–1632)

Abstract Moderator(s)

• KE

  Keith Elkon, MD

  University of Washington
  Seattle, WA, United States

  Disclosure(s): No financial relationships with ineligible companies to disclose
• 

  Jennifer Barnas, MD, PhD, BS

  University of Rochester
  Rochester, NY, United States

  Disclosure(s): No financial relationships with ineligible companies to disclose

Oral abstract session.

Presentations:

• 9:00 AM – 9:10 AM Eastern Time

  AUR200: An Improved BAFF/APRIL Inhibitor with Increased Potency and Safety for the Treatment of B Cell-Mediated Diseases
  

  Presenting Author: Shawn Morales – Aurinia Pharmaceuticals, Inc.
• 9:10 AM – 9:15 AM Eastern Time

  Q&A
  
• 9:15 AM – 9:25 AM Eastern Time

  Single-cell Profiling of B Cell Repertoire and Gene Expression in the RA Synovium Reveals Tissue Specific Clonal Expansion
  

  Presenting Author: Nida Meednu, PhD – University of Rochester Medical center
• 9:25 AM – 9:30 AM Eastern Time

  Q&A
  
• 9:30 AM – 9:40 AM Eastern Time

  Phospholipase D 4 Is a Novel Surface Marker of a Distinctive B Cell Population Overlapping with Double Negative 2 B Cells
  

  Presenting Author: Ken Yasaka, MD – Tohoku University School of Medicine
• 9:40 AM – 9:45 AM Eastern Time

  Q&A
  
• 9:45 AM – 9:55 AM Eastern Time

  Novel Autoantibodies Identify Sjögren’s Disease in Patients Lacking Serum IgG Specific for Ro/SS-A and La/SS-B
  

  Presenting Author: A. Darise Farris, PhD – Oklahoma Medical Research Foundation
• 9:55 AM – 10:00 AM Eastern Time

  Q&A